Koa Shoji Holdings Co.,Ltd. (9273.T)
JPY 647.0
(1.73%)
JPY 647.0
(1.73%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 6.63 Billion JPY | 3.05% |
| 2022 | 6.44 Billion JPY | 8.57% |
| 2021 | 5.93 Billion JPY | 6.94% |
| 2020 | 5.54 Billion JPY | 18.77% |
| 2019 | 4.67 Billion JPY | 26.67% |
| 2018 | 3.68 Billion JPY | 5.74% |
| 2017 | 3.48 Billion JPY | -14.91% |
| 2016 | 4.09 Billion JPY | 9.22% |
| 2015 | 3.75 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q3 | 1.68 Billion JPY | -2.72% |
| 2023 Q4 | 1.49 Billion JPY | -11.58% |
| 2023 Q1 | 1.72 Billion JPY | 4.91% |
| 2023 FY | 6.63 Billion JPY | 3.05% |
| 2023 Q2 | 1.73 Billion JPY | 0.73% |
| 2022 Q4 | 1.64 Billion JPY | 2.22% |
| 2022 FY | 6.44 Billion JPY | 8.57% |
| 2022 Q1 | 1.52 Billion JPY | 8.34% |
| 2022 Q2 | 1.67 Billion JPY | 9.92% |
| 2022 Q3 | 1.6 Billion JPY | -3.92% |
| 2021 FY | 5.93 Billion JPY | 6.94% |
| 2021 Q4 | 1.4 Billion JPY | 2.41% |
| 2021 Q3 | 1.37 Billion JPY | -23.46% |
| 2021 Q2 | 1.79 Billion JPY | 31.07% |
| 2021 Q1 | 1.36 Billion JPY | -6.64% |
| 2020 Q2 | 1.4 Billion JPY | 11.14% |
| 2020 Q1 | 1.26 Billion JPY | -12.69% |
| 2020 FY | 5.54 Billion JPY | 18.77% |
| 2020 Q4 | 1.46 Billion JPY | 3.66% |
| 2020 Q3 | 1.41 Billion JPY | 0.4% |
| 2019 Q2 | 1.4 Billion JPY | 101.55% |
| 2019 Q4 | 1.44 Billion JPY | 29.43% |
| 2019 Q3 | 1.12 Billion JPY | -20.27% |
| 2019 FY | 4.67 Billion JPY | 26.67% |
| 2019 Q1 | 697.03 Million JPY | -45.07% |
| 2018 Q3 | 835.12 Million JPY | 3.06% |
| 2018 Q1 | 773.76 Million JPY | -21.89% |
| 2018 FY | 3.68 Billion JPY | 5.74% |
| 2018 Q4 | 1.26 Billion JPY | 51.94% |
| 2018 Q2 | 810.32 Million JPY | 4.72% |
| 2017 FY | 3.48 Billion JPY | -14.91% |
| 2017 Q4 | 990.6 Million JPY | 0.0% |
| 2017 Q3 | - JPY | 0.0% |
| 2016 FY | 4.09 Billion JPY | 9.22% |
| 2015 FY | 3.75 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | 86.381% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 99.696% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 96.468% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 98.201% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -87.514% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 93.156% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | 82.629% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 98.868% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -10.697% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 91.592% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 87.249% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | 50.88% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | 14.195% |
| Tsumura & Co. | 68.81 Billion JPY | 90.352% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | 82.219% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | 73.219% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 91.842% |
| Fuji Pharma Co., Ltd. | 16.51 Billion JPY | 59.797% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | 86.769% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | 87.082% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -515.348% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | 32.518% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -50.523% |
| MedRx Co., Ltd | 26 Million JPY | -25436.931% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | 17.271% |
| Solasia Pharma K.K. | 337 Million JPY | -1870.208% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 908390.287% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | 78.348% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 87.777% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -17491.146% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 94.123% |